Skip to content

Order Reagents

Search for:

Proprietary SRG Rat^®
- Oncology Applications
Gene Editing Platforms
- Cas-Clover™
- piggyBac^®
Gene Editing Services
Research Services
About Us
Resources
Contact Us

Search for:

Proprietary SRG Rat^®
- Oncology Applications
Gene Editing Platforms
- Cas-Clover™
- piggyBac^®
Gene Editing Services
Research Services
About Us
Resources
Contact Us

Case Study

Improving Preclinical Anticancer Studies Using Rat Xenograft Model Systems

Jack Crawford2022-09-30T15:45:38+00:00

Recent Posts

Hera Biolabs Announces Molecular Cancer Therapeutics Publication On Immunodeficient Rats For Oncology Research
October 19, 2018
OncoRat® PDX Models Highlighted In Drug Discovery News (DDN) Special Report On Cancer: Aiming For Avatars
July 18, 2018
Humanized Mice Allow For Better Understanding Of Interactions Between VACV & Immune System
June 29, 2017
Humanized Mouse Model Allows For Study Of Immune Response To Decellularized ECM Biomaterials
June 23, 2017
New Mouse Model Enables In Vivo Assessment Of Immunotherapies For Treating CGD
April 27, 2017
Patient Derived Xenografts Possess Significant Advantages In The Study Of Urological Tumors
April 27, 2017

Sign Up for Our Newsletter Contact Us

Ask a Question.

Title

Our Vision

Our vision is to bring superior clinical predictability to preclinical research activities through genetically modified models, humanized rodent models, and cell-line creation.

Proprietary SRG Rat^®
Research Services
Gene Editing Platforms
Gene Editing Services
About Us
Resources

Newsletter

Sign up to our newsletter to be up to date With out latest happenings.

Email(Required)

Comments

This field is for validation purposes and should be left unchanged.

© 2025, Hera Biolabs. All Rights Reserved.